# Voyagers Capital

> Voyagers Capital is a VC fund backing Biotechnology, Medical and Health Care. See 5 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Total investments: 5
- Last investment: Mar 2026
- Lead investor: 40%
- Last updated: Aug 2026

Voyagers Capital is a specialized investment company that concentrates on the medical and healthcare sector while considering both domestic and international markets.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 3 | 60% |
| Medical | 2 | 40% |
| Health Care | 2 | 40% |
| Life Science | 2 | 40% |
| Pharmaceutical | 2 | 40% |

8 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 2 | 40% |
| Angel | 1 | 20% |
| Series C | 1 | 20% |
| Venture - Series Unknown | 1 | 20% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| China | 4 | 80% |
| United States | 1 | 20% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| iCamumo | Aikai Biotech is focused on developing a new generation of off-the-shelf general-purpose cell therapy pharmaceuticals using iPSC. | $14.4M | Series A | Mar 09, 2026 |  |
| GeneMind Biosciences | GeneMind Biosciences is a domestic third-generation single-molecule gene sequencing system. GeneMind Biosciences has been fighting to provide better gene sequencing solutions for clinicians and researchers. A Gene sequencer is the crown jewel in the field of gene sequencing. Entrepreneurs will lead their innovations and breakthroughs throughunremitting research and exploration. GeneMind believes that the strong pass of the difficulty is like a wall of iron, yet with firm strides, we are conquering its summit. | $38.6M | Venture - Series Unknown | Mar 10, 2025 |  |
| Alpine Medical | Alpine focuses on the research and development and industrialization of innovative medical devices in the field of heart failure, and is committed to providing safe, effective and affordable treatment solutions for patients around the world. | $7M | Angel | Feb 22, 2025 |  |
| SanVectron | SanVectron is a medical device company specializing in the sales, production, and distribution of medical devices, as well as the sales of laboratory analysis instruments. | $27.4M | Series A | Dec 23, 2024 |  |
| Cullgen | Cullgen is a drug discovery service intended to create new drugs for the treatment of diseases that currently lack effective therapies. The company's services use protein degradation technology that focuses on the selective degradation of disease-causing proteins, a novel treatment for cancer, inflammatory and autoimmune diseases, includingtargets previously considered undruggable, enabling scientists with new means to develop novel therapeutic approaches for various diseases. | $35M | Series C | May 08, 2023 |  |

5 of 5 investments shown.

## Co-investors
- [AstraZeneca-CICC Venture Capital](https://shizune.co/investors/profile/astrazeneca-cicc-venture-capital) — VC Fund, 2 deals together
- Rongquan Venture Capital — VC Fund, 2 deals together
- Sansure Biotech — VC Fund, 2 deals together
- [GNI Japan](https://shizune.co/investors/profile/gni-japan) — VC Fund, 1 deal together
- InnoVision Capital — VC Fund, 1 deal together
- [JinHe Ziben](https://shizune.co/investors/profile/jinhe-ziben) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Voyagers Capital invest in?

Voyagers Capital invests primarily in Biotechnology, Medical and Health Care startups, most often at Series A and Angel stage. Most of the 5 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Voyagers Capital last invest?

The most recent investment recorded for Voyagers Capital closed in Mar 2026. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co